Metropolitan Life Insurance Company (MetLife)’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-78
| Closed | -$17.5K | – | 2374 |
|
|
2022
Q3 | $17.5K | Hold |
78
| – | – | ﹤0.01% | 2087 |
|
|
2022
Q2 | $14.7K | Hold |
78
| – | – | ﹤0.01% | 2195 |
|
|
2022
Q1 | $19.3K | Buy |
+78
| New | +$19.3K | ﹤0.01% | 2113 |
|
|
2021
Q1 | – | Sell |
-278
| Closed | -$102K | – | 2603 |
|
|
2020
Q4 | $102K | Hold |
278
| – | – | ﹤0.01% | 2354 |
|
|
2020
Q3 | $67.8K | Hold |
278
| – | – | ﹤0.01% | 2416 |
|
|
2020
Q2 | $79.9K | Buy |
+278
| New | +$79.9K | ﹤0.01% | 2382 |
|
|
2020
Q1 | – | Sell |
-269
| Closed | -$120K | – | 2556 |
|
|
2019
Q4 | $120K | Sell |
269
-36
| -12% | -$16.1K | ﹤0.01% | 2223 |
|
|
2019
Q3 | $93.7K | Buy |
305
+239
| +362% | +$73.4K | ﹤0.01% | 2336 |
|
|
2019
Q2 | $21.1K | Buy |
+66
| New | +$21.1K | ﹤0.01% | 2602 |
|